Baillie Gifford & Co
MXCT icon

Baillie Gifford & Co’s MaxCyte MXCT Stock Holding History

Baillie Gifford & Co’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-293,325
Closed -$1.41M – 389
2023
Q1 		$1.41M Hold
293,325
– – ﹤0.01% 262
2022
Q4 		$1.54M Buy
293,325
+90,525
+45% +$555K ﹤0.01% 265
2022
Q3 		$1.31M Buy
+202,800
New +$1.13M ﹤0.01% 265

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Baillie Gifford & Co's MXCT Position: Q2 2023 in Review

Baillie Gifford & Co sold out of MaxCyte (MXCT) in Q2 2023, closing a stake of 293,325 shares — an estimated $1.41M sold.

Baillie Gifford & Co first reported a position in MXCT in Q3 2022 and held it in 3 quarters. The position peaked at $1.54M in Q4 2022. 116 funds tracked by Wall St. Rank hold MXCT as of Q2 2023.

  • Baillie Gifford & Co reported no remaining MaxCyte position as of Q2 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 293,325 MaxCyte shares in Q2 2023, an estimated $1.41M.
  • Baillie Gifford & Co first reported a position in MaxCyte in Q3 2022 and held it in 3 quarters.
  • Baillie Gifford & Co's MaxCyte position peaked at $1.54M in Q4 2022.
  • 116 funds tracked by Wall St. Rank held MaxCyte as of Q2 2023.

Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.